(Q37201179)

18 August 2017

1 reference

title

Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma? (English)

1 reference

18 August 2017

1 reference

Peter Hellstern

1

1 reference

18 August 2017

25 June 2008

1 reference

Transfusion and Apheresis Science

18 August 2017

1 reference

18 August 2017

39

1 reference

18 August 2017

1

1 reference

18 August 2017

69-74

1 reference

Update on pathogen reduction technology for therapeutic plasma: an overview

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Pathogen-reduction systems for blood components: the current position and future trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

What's happening? The quality of methylene blue treated FFP and cryo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Levels of von Willebrand factor-cleaving protease are normal in methylene blue-treated fresh-frozen plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Solvent/detergent-treated plasma: composition, efficacy, and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Composition, efficacy, and safety of S/D-treated plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Manufacture and in vitro characterization of a solvent/detergent-treated human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Universal fresh frozen plasma (Uniplas): a safe product in open-heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.005

10.1016/J.TRANSCI.2008.05.005

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18583192